4 Cardiomyopathy Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Cardiomyopathy Studies in Tucson

NCT07358078Recruiting

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

The purpose of this study is to: * Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) treated with vutrisiran in routine cli...

Tucson, AZ2,000 participantsAlnylam Pharmaceuticals

View Study Details

NCT05489705Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructi...

Tucson, AZ1,700 participantsBristol-Myers Squibb

View Study Details

NCT06128629Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM....

Tucson, AZPHASE31,200 participantsIntellia Therapeutics

View Study Details

NCT05180773Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...

Tucson, AZPHASE4250 participantsDennis M. McNamara, MD, MS

View Study Details

About Cardiomyopathy Clinical Trials in Tucson

Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.

There are currently 4 cardiomyopathy clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 5,150 participants. Research is being sponsored by Alnylam Pharmaceuticals, Bristol-Myers Squibb, Intellia Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Cardiomyopathy Clinical Trials in Tucson — FAQ

Are there cardiomyopathy clinical trials in Tucson?

Yes, there are 4 cardiomyopathy clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What cardiomyopathy treatments are being tested?

The 4 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.

Data updated October 14, 2026 from ClinicalTrials.gov